Name
6A: Vaccines
Date & Time
Friday, November 7, 2025, 9:00 AM - 10:15 AM
Description
Presentations:
- Identification of maternal, genetic and medical factors that influence rotavirus vaccine efficacy in a large-scale clinical trial in Vietnamese infants
- Sarah Caddy, Baker Institute for Animal Health, Cornell University
- MVA viral vaccine vectors expressing VP2 or VP7 confer full protection against epizootic hemorrhagic disease virus in the IFNAR(-/-) mice model
- Javier Ortego, CISA-INIA, CSIC
- Novel antibody-dependent intracellular neutralization assay to assess rotavirus vaccine efficacy
- Sarah Woodyear, Cornell University
- A rotavirus VP4 or VP7 monoreassortant panel identifies genotypes that are less susceptible to neutralization by systemic antibodies induced by vaccination or natural infection
- Tomohiro Kotaki, Osaka University